Contributions of BetaCellBoyd

Contributions by BetaCellBoyd, newest first. This list covers edits recorded in the site's change log; the editor's lifetime total of 2,866 edits includes activity predating the current log.

1. 14:05, 15 Jul 2026 (diff | hist) Syringe dead space 20,968 ±0 m correct percentage: source reports placebo-adjusted
2. 23:57, 21 Jun 2026 (diff | hist) Glucagon-like peptide-1 12,294 ±0 m add DOI
3. 10:24, 1 Feb 2026 (diff | hist) Glucagon-like peptide-1 12,294 ±0 m typo
4. 11:00, 20 Jul 2025 (diff | hist) Chinese Peptide Company 11,690 +1,024 correct percentage: source reports placebo-adjusted
5. 01:53, 27 May 2025 (diff | hist) Glucose-dependent insulinotropic polypeptide 6,898 ±0 copyedit
6. 18:35, 29 Apr 2025 (diff | hist) GL Biochem (Shanghai) 11,870 ±0 m convert prose to table for comparability
7. 19:20, 11 Mar 2025 (diff | hist) Wuhan Wansheng Biotechnology 8,522 ±0 m fix significant figures — source gives fewer
8. 23:41, 7 Mar 2025 (diff | hist) Insulin syringe unit conversion 3,664 ±0 rv unexplained removal of sourced content
9. 17:41, 26 Feb 2025 (diff | hist) Beyond-use date 11,093 +618 rv unexplained removal of sourced content
10. 11:35, 7 Nov 2024 (diff | hist) Shanghai Sigma-Audley New Material Technology 2,340 +484 label community tally as self-reported
11. 03:09, 29 Oct 2024 (diff | hist) Incretin effect 4,860 +57 add hatnote
12. 16:34, 22 Jul 2024 (diff | hist) Glucose-dependent insulinotropic polypeptide 2,551 ±0 m typo
13. 10:15, 18 Jun 2024 (diff | hist) Incretin effect 1,841 ±0 correct transposed digits